Sign in Subscribe
Aspirin

Aspirin Use May Lower Colorectal Cancer Risk for High-Risk Individuals

Strategic Insights

— 1 min read

A study has found that regular use of aspirin could lower colorectal cancer risk, particularly among individuals with lifestyle risk factors such as smoking or obesity. However, individuals with the healthiest lifestyle have low colon cancer risk regardless of aspirin intake. The findings of this study do not change the recommendations of the United States Preventative Services Task Force (USPSTF), which advised against the use of aspirin to prevent colon cancer due to a lack of evidence and potential complications.

Key Takeaways:

  • Regular use of aspirin may lower colorectal cancer risk in individuals with lifestyle risk factors such as smoking or obesity.
  • Individuals with the healthiest lifestyle have low colon cancer risk regardless of aspirin intake.
  • The USPSTF advised against the use of aspirin to prevent colon cancer in 2022 due to a lack of evidence and potential complications.
  • Colorectal surgeon Dr. Jason Zell emphasizes the importance of diet and lifestyle modifications in preventing colorectal cancer.
  • Dr. Zell suggests routine screening starting at age 45 and calls for individuals to notify their primary care physician if they notice anything unusual.
  • Dr. Zell specializes in the prevention and treatment of colon and other gastrointestinal cancers at the UCI Health Chao Family Comprehensive Cancer Center.
  • He is also an associate professor in the Division of Hematology/Oncology at the UC Irvine School of Medicine.
  • A leading cancer researcher, Dr. Zell has received funding from the National Institutes of Health (NIH) to perform genetic epidemiology-based colorectal cancer research.

Statistics:

  • Colorectal cancer is a significant health concern, with approximately 153,000 new cases diagnosed in the United States in 2022 (Source: [National Cancer Institute (2022)]).
  • The risk of colorectal cancer increases with age, with the rate of new cases increasing significantly after the age of 50 (Source: [National Cancer Institute (2022)]).
  • The USPSTF advised against the use of aspirin to prevent colon cancer in 2022 due to a lack of evidence and potential complications, including ulcers (Source: [USPSTF (2022)]).
  • Individuals with the healthiest lifestyle have low colon cancer risk, regardless of aspirin intake (Source: [UCI Health (2022)]).
  • Dr. Zell has received funding from the National Institutes of Health (NIH) to perform genetic epidemiology-based colorectal cancer research (Source: [UCI Health (2022)]).

Sources:

  • [Category: Health Care Services and Facilities, Health Care, Clinical Trials]
  • National Cancer Institute (2022)
  • USPSTF (2022)
  • UCI Health (2022)

Read more